Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14601 - 14625 of 14677 in total
EVT 201 is a novel partial positive allosteric modulator of the GABAA receptor complex which is being developed as a treatment for insomnia. It is being developed by Evotec Inc.
Investigational
Doramapimod is a P38 MAP kinase inhibitor.
Investigational
Albaconazole has been used in trials studying the basic science of Onychomycosis.
Investigational
Experimental
TAK-475 is a "squalene synthase inhibitor", a type of cholesterol-lowering drug that has not yet been brought to market.
Investigational
Experimental
Experimental
Displaying drugs 14601 - 14625 of 14677 in total